Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Lois E. Shepherd
Based on 46 articles published since 2009
(Why 46 articles?)
||||
Expertise Level
The expertise of Lois E. Shepherd ranks in the
  • Top 0.18%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Shepherd, L E   ·   Shepherd, Lois   ·   Shepherd, Lois E
Work Locations
Details
Most likely:    Queen's University      
2018
  • Wilhelminen Hospital, Vienna, Austria. Electronic address: · Southlake Regional Health Centre, Ontario, Canada; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Nova Scotia Cancer Centre, NS, Canada; Dalhousie University, NS, Canada. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Mae de Deus Cancer Institute, Porto Alegre, RS, Brazil; Servico de Oncologia, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Pubmed 29274617
  • Department of Internal Medicine, Baylor College of Medicine, Houston, TX. Electronic address: · Department of Internal Medicine, Queens University Cancer Research Institute, Queen's Cancer Research Institute, Kingston, Ontario, Canada. · Department of Internal Medicine, Baylor College of Medicine, Houston, TX. · Department of Internal Medicine, Vanderbilt University, Nashville, TN. · Department of Internal Medicine, Mayo Clinic, Rochester, MN. · Department of Internal Medicine, Queens University Cancer Research Institute, Kingston, Ontario, Canada. · Department of Internal Medicine, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Department of Internal Medicine, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. · Department of Internal Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Internal Medicine, Harvard Medical School, Boston, MA. · Pubmed 29128193
2017
  • Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA. · Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada. · Oncology, GlaxoSmithKline, Collegeville, PA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Walt Carney Biomarkers Consulting, LLC Cambridge, Boston, MA, USA. · Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA. · Pubmed 28484925
  • Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, Pennsylvania. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada. · Oncology, Mayo Clinic, Rochester, Minnesota. · Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Stanford University Medical Center, Stanford, California. · International Breast Cancer Study Group Coordinating Center and Inselspital, Bern, Switzerland. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Lebanon VA Medical Center, Lebanon, Pennsylvania. · Pubmed 28464211
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Department of Pathology and Laboratory Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, Canada. · British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 28750133
  • Department of Medical Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva and Tel-Aviv University, Tel Aviv, Israel. · Canadian Cancer Trials Group (CCTG; Formerly, NCIC Clinical Trials Group), Queen's University, Kingston, Canada. · Massachusetts General Hospital Cancer Center, Boston, USA. · Department of Medical Oncology, Jewish General Hospital, McGill University, Montreal. · Department of Medical Oncology, Saint John Regional Hospital, Saint John. · Department of Oncology, McMaster University, Juravinski Cancer Center, Hamilton, Ontario. · Department of Medical Oncology, Tom Baker Cancer Centre, Alberta Health Services and University of Calgary, Calgary. · Department of Medical Oncology, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario. · Department of Oncology, Mayo Clinic, Rochester, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 28379421
2016
  • Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · Massachusetts General Hospital, Harvard University, Boston, MA, USA. · bioTheranostics Inc, San Diego, CA, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · McGill University, Montreal, QC, Canada. · Pubmed 27116182
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG) and Queen's University, Kingston, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON Canada. · Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON Canada. · Saint John Regional Hospital, Saint John, MB, Canada. · Ontario Clinical Oncology Group, McMaster University, Hamilton, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Edinburgh, UK. · Pubmed 27056899
  • Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 27006189
  • The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada. Electronic address: · Notre-Dame Hospital, CHUM, Montreal, Quebec, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, Canada. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. · Pubmed 26986765
  • Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · Trovagene Inc., San Diego, CA, USA. · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Pubmed 26728744
2015
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
  • Ontario Institute for Cancer Research, 661 University Avenue, Suite 510, Toronto, Ontario M5G 0A3, Canada. · Genetic Pathology Evaluation Centre, British Columbia (BC) Cancer Agency, Vancouver, British Columbia V5Z 1M9, Canada. · BC Cancer Agency, University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada. · NCIC Clinical Trials Group, Queen's University, 10 Stuart Street, Kingston, Ontario K7L 3N6, Canada. · Saint John Regional Hospital, Saint John, New Brunswick E2L 4L4, Canada. · Juravinski Cancer Clinic, Hamilton Health Sciences, McMaster University, Hamilton, Ontario L8V 5C2, Canada. · Pubmed 26284338
2014
  • Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Columbia University Medical Center, New York, NY, USA. · University of Toronto, Toronto, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · Johns Hopkins Oncology Centre, School of Medicine, Baltimore, MD, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Carle CCOP, Urbana-Champaign, IL, USA. · University of North Carolina/Lineberger Comp Cancer Center, Chapel Hill, NC, USA. · University of Washington, Seattle, WA, USA. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Massachusetts General Hospital, Boston, MA, USA. · Pubmed 24636210
2015
  • NCIC Clinical Trials Group, Queen's University, 10 Stuart Street, Kingston, ON, K7L 3N6, Canada, · Pubmed 26276354
2013
  • NCIC Clinical Trials Group, Queens University, Kingston, ON, Canada. · Pubmed 24113743
Probable:    Miscellaneous institutions in Kingston, ON      
2018
  • Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC, 27151, USA. · Dana Farber Cancer Institute, Boston, MA, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Canadian Cancer Trials Group (CCTG), Kingston, Canada. · McMaster University, Hamilton, ON, Canada. · Wichita NCORP, Wichita, KA, USA. · Michiana Hematology-Oncology, P.C., Mishawaka, IN, USA. · Swedish American Regional Cancer Center, Rockford, IL, USA. · Mercy Hospital-Joplin, Joplin, MO, USA. · Mercy Hospital, Coon Rapids, MN, USA. · West Michigan Cancer Center, Kalamazoo, MI, USA. · Essentia Health Cancer Center, Duluth, MN, USA. · Stanford University, Stanford, CA, USA. · Northwestern University, Chicago, IL, USA. · Pubmed 29455298
2016
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Baylor Breast Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts. · Canadian Cancer Trials Group, Kingston, Ontario, Canada. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · University of Tokyo, Tokyo, Japan. · Johns Hopkins School of Medicine, Baltimore, Maryland. · Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Pubmed 27758888
Probable:    Miscellaneous cities in Ontario      
2013
  • Department of Oncology and Surgery, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada. · Department of Pathology, Jewish General Hospital, Montreal, Quebec, Canada. · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Ontario, Canada. · Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pubmed 24367492
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Lois E. Shepherd about Breast Neoplasms:

  • Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27. 2018
  • Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27. 2018
  • Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03). 2018
  • Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab). 2017
  • Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27. 2017
  • Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. 2017
  • Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. 2017
  • Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials. 2017
  • Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14. 2016
  • A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial. 2016
Show List of Full Article Records
Google Searches

Learn more about Lois E. Shepherd using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Queen's University
Miscellaneous institutions in Kingston, ON
Miscellaneous cities in Ontario
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Queen's University
2018
  • Wilhelminen Hospital, Vienna, Austria. Electronic address: · Southlake Regional Health Centre, Ontario, Canada; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Nova Scotia Cancer Centre, NS, Canada; Dalhousie University, NS, Canada. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Mae de Deus Cancer Institute, Porto Alegre, RS, Brazil; Servico de Oncologia, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Pubmed 29274617
  • Department of Internal Medicine, Baylor College of Medicine, Houston, TX. Electronic address: · Department of Internal Medicine, Queens University Cancer Research Institute, Queen's Cancer Research Institute, Kingston, Ontario, Canada. · Department of Internal Medicine, Baylor College of Medicine, Houston, TX. · Department of Internal Medicine, Vanderbilt University, Nashville, TN. · Department of Internal Medicine, Mayo Clinic, Rochester, MN. · Department of Internal Medicine, Queens University Cancer Research Institute, Kingston, Ontario, Canada. · Department of Internal Medicine, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Department of Internal Medicine, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. · Department of Internal Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Internal Medicine, Harvard Medical School, Boston, MA. · Pubmed 29128193
2017
  • Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA. · Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada. · Oncology, GlaxoSmithKline, Collegeville, PA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Walt Carney Biomarkers Consulting, LLC Cambridge, Boston, MA, USA. · Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA. · Pubmed 28484925
  • Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, Pennsylvania. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada. · Oncology, Mayo Clinic, Rochester, Minnesota. · Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Stanford University Medical Center, Stanford, California. · International Breast Cancer Study Group Coordinating Center and Inselspital, Bern, Switzerland. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Lebanon VA Medical Center, Lebanon, Pennsylvania. · Pubmed 28464211
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. · Department of Pathology and Laboratory Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, Canada. · British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 28750133
  • Department of Medical Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva and Tel-Aviv University, Tel Aviv, Israel. · Canadian Cancer Trials Group (CCTG; Formerly, NCIC Clinical Trials Group), Queen's University, Kingston, Canada. · Massachusetts General Hospital Cancer Center, Boston, USA. · Department of Medical Oncology, Jewish General Hospital, McGill University, Montreal. · Department of Medical Oncology, Saint John Regional Hospital, Saint John. · Department of Oncology, McMaster University, Juravinski Cancer Center, Hamilton, Ontario. · Department of Medical Oncology, Tom Baker Cancer Centre, Alberta Health Services and University of Calgary, Calgary. · Department of Medical Oncology, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada. · Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario. · Department of Oncology, Mayo Clinic, Rochester, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 28379421
2016
  • Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · Massachusetts General Hospital, Harvard University, Boston, MA, USA. · bioTheranostics Inc, San Diego, CA, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Canadian Cancer Trials Group (Formerly, NCIC Clinical Trials Group), Queen's University, 10 Stuart St, Kingston, ON, Canada. · McGill University, Montreal, QC, Canada. · Pubmed 27116182
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG) and Queen's University, Kingston, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON Canada. · Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON Canada. · Saint John Regional Hospital, Saint John, MB, Canada. · Ontario Clinical Oncology Group, McMaster University, Hamilton, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Edinburgh, UK. · Pubmed 27056899
  • Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Canadian Cancer Trials Group (formerly, NCIC Clinical Trials Group), Queen's University, Kingston, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 27006189
  • The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada. Electronic address: · Notre-Dame Hospital, CHUM, Montreal, Quebec, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, Canada. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. · Pubmed 26986765
  • Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · Molecular Pathology Unit, Pathology Research Center, Massachusetts General Hospital, MGH East, Molecular Pathology, Research, 149 13th Street, Charlestown, MA, 02129, USA. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Pathology, Harvard Medical School, Boston, MA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · bioTheranostics, Inc., San Diego, CA, USA. · Trovagene Inc., San Diego, CA, USA. · Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. · Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Pubmed 26728744
2015
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. · Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Leeds Institute of Cancer and Pathology and Cancer Research UK Centre, St James' University Hospital, Leeds, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of Toronto, Toronto, ON, Canada. · McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. · NCIC Clinical Trials Group (NCIC CTG] and Queen's University, Kingston, ON, Canada. · Pubmed 26372731
  • Ontario Institute for Cancer Research, 661 University Avenue, Suite 510, Toronto, Ontario M5G 0A3, Canada. · Genetic Pathology Evaluation Centre, British Columbia (BC) Cancer Agency, Vancouver, British Columbia V5Z 1M9, Canada. · BC Cancer Agency, University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada. · NCIC Clinical Trials Group, Queen's University, 10 Stuart Street, Kingston, Ontario K7L 3N6, Canada. · Saint John Regional Hospital, Saint John, New Brunswick E2L 4L4, Canada. · Juravinski Cancer Clinic, Hamilton Health Sciences, McMaster University, Hamilton, Ontario L8V 5C2, Canada. · Pubmed 26284338
2014
  • Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Columbia University Medical Center, New York, NY, USA. · University of Toronto, Toronto, ON, Canada. · Mayo Clinic, Rochester, MN, USA. · Johns Hopkins Oncology Centre, School of Medicine, Baltimore, MD, USA. · Allan Blair Cancer Centre, Regina, SK, Canada. · Carle CCOP, Urbana-Champaign, IL, USA. · University of North Carolina/Lineberger Comp Cancer Center, Chapel Hill, NC, USA. · University of Washington, Seattle, WA, USA. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · NCIC Clinical Trials Group, Queen's University, Kingston, ON, Canada. · Massachusetts General Hospital, Boston, MA, USA. · Pubmed 24636210
2015
  • NCIC Clinical Trials Group, Queen's University, 10 Stuart Street, Kingston, ON, K7L 3N6, Canada, · Pubmed 26276354
2013
  • NCIC Clinical Trials Group, Queens University, Kingston, ON, Canada. · Pubmed 24113743
Miscellaneous institutions in Kingston, ON
2018
  • Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC, 27151, USA. · Dana Farber Cancer Institute, Boston, MA, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Canadian Cancer Trials Group (CCTG), Kingston, Canada. · McMaster University, Hamilton, ON, Canada. · Wichita NCORP, Wichita, KA, USA. · Michiana Hematology-Oncology, P.C., Mishawaka, IN, USA. · Swedish American Regional Cancer Center, Rockford, IL, USA. · Mercy Hospital-Joplin, Joplin, MO, USA. · Mercy Hospital, Coon Rapids, MN, USA. · West Michigan Cancer Center, Kalamazoo, MI, USA. · Essentia Health Cancer Center, Duluth, MN, USA. · Stanford University, Stanford, CA, USA. · Northwestern University, Chicago, IL, USA. · Pubmed 29455298
2016
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Baylor Breast Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts. · Canadian Cancer Trials Group, Kingston, Ontario, Canada. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · University of Tokyo, Tokyo, Japan. · Johns Hopkins School of Medicine, Baltimore, Maryland. · Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Pubmed 27758888
Unspecified
2015
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
  • Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD · Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada · Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO · Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX · James N. Ingle, Mayo Clinic, Rochester, MN · G. Thomas Budd, Cleveland Clinic, Cleveland, OH · George W. Sledge, Stanford University, San Francisco, CA · Pedro E.R. Liedke and Paul E. Goss, Harvard University · Paul E. Goss, Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA · Manuela Rabaglio, Inselspital University Hospital and International Breast Cancer Study Group Coordinating Center, Berne, Switzerland · and Pedro E.R. Liedke, Hospital de Clínicas de Porto Alegre and Instituto do Cancer Mãe de Deus, Oncologia, Porto Alegre, Rio Grande do Sul, Brazil. · Pubmed 25512454
Miscellaneous cities in Ontario
2013
  • Department of Oncology and Surgery, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada. · Department of Pathology, Jewish General Hospital, Montreal, Quebec, Canada. · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Ontario, Canada. · Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pubmed 24367492
28 Other Locations Show
Yearly article counts 035610286510
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.